Inflammation plays an important role in the pathophysiology of ischemic stroke; numerous studies have indicated that plasma levels of IL-6, C-reactive protein and other pro-inflammatory cytokines correlate with brain infarct volume and stroke severity and are early markers for long-term outcomes in AIS patients [18–20]. This evidence concerns the gene CRP and stroke disorder.